Study S000130

Exendin PET/CT for Paragangliomas

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05418907
Acronym: ENTRAP
Study type: OBSERVATIONAL
Status: UNKNOWN
Enrollment: 10
Start: 2022-06-01
Primary completion: 2024-12-01
Lead sponsor: Radboud University Medical Center
Conditions: Paraganglioma
Interventions: RADIATION:68Ga-NODAGA-exendin-4 PET/CT
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

detection rate of PGL's using 68Ga-exendin-4 PET/CT [1 year]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0007290	Sex Differences in [ 68Ga]Ga-NODAGA-Exendin-4 Uptake in the Pituitary of Individuals With Type 2 Diabetes. Tokgöz S, Diabetes, obesity & metabolism	2026	Nonrandomized study	PMID 41766452 DOI	cites ClinicalTrials.gov:NCT05418907